GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » PEG Ratio

Consun Pharmaceutical Group (HKSE:01681) PEG Ratio : 0.35 (As of May. 18, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Consun Pharmaceutical Group's PE Ratio without NRI is 6.51. Consun Pharmaceutical Group's 5-Year EBITDA growth rate is 18.60%. Therefore, Consun Pharmaceutical Group's PEG Ratio for today is 0.35.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Consun Pharmaceutical Group's PEG Ratio or its related term are showing as below:

HKSE:01681' s PEG Ratio Range Over the Past 10 Years
Min: 0.24   Med: 0.48   Max: 11.07
Current: 0.35


During the past 12 years, Consun Pharmaceutical Group's highest PEG Ratio was 11.07. The lowest was 0.24. And the median was 0.48.


HKSE:01681's PEG Ratio is ranked better than
95.92% of 368 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs HKSE:01681: 0.35

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Consun Pharmaceutical Group PEG Ratio Historical Data

The historical data trend for Consun Pharmaceutical Group's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group PEG Ratio Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.93 0.50 0.47 0.40 0.24

Consun Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 - 0.40 - 0.24

Competitive Comparison of Consun Pharmaceutical Group's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's PEG Ratio falls into.



Consun Pharmaceutical Group PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Consun Pharmaceutical Group's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=6.5051258154706/18.60
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Consun Pharmaceutical Group  (HKSE:01681) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Consun Pharmaceutical Group PEG Ratio Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (HKSE:01681) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines